Coya Therapeutics, Inc. (COYA) vs Caribou Biosciences, Inc. (CRBU)
A side-by-side comparison of Coya Therapeutics, Inc. and Caribou Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.86HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CRBU
Caribou Biosciences, Inc.
$1.19HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — COYA vs CRBU
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)CRBU -80.3% (-33.4%/yr)COYA compounded faster over this window
Log scale — wide-divergence pair
COYA CRBU
COYA vs CRBU: by the numbers
- •CRBU is the larger company ($118M vs $114M market cap).
- •Both run net losses; COYA's is the smaller (-270.22% vs -1030.42% net margin).
Metrics side by side
Valuation
| Metric | COYA | CRBU |
|---|---|---|
| P/S ratio | 14.22 | 11.76 |
| P/B ratio | 0.00 | 1.20 |
Profitability
| Metric | COYA | CRBU |
|---|---|---|
| Gross margin | 99.91% | 67.34% |
| Operating margin | -255.05% | -1220.49% |
| Net margin | -270.22% | -1030.42% |
| ROE | -0.05% | -105.40% |
| ROIC | -0.05% | -87.72% |
Growth (annualized)
| Metric | COYA | CRBU |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -2.03% |
| Total return CAGR (5Y) | N/A | -44.43% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.